Platelet activation induced by porcine factor VIII (Hyate:C)

American Journal of Hematology

Volumn 57, Issue 3, 1998, Pages 200-205

  Chang, H ^a   Mody, M ^a   Lazarus, A M ^a   Ofosu, F ^c   Garvey, M B ^a   Blanchette, V ^b   Teitel, J ^a   Freedman, J ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Hemophilia; Platelet activation; Platelets; Porcine factor VIII

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; CD36 ANTIGEN; CD42 ANTIGEN; CD63 ANTIGEN; FIBRINOGEN RECEPTOR; MEMBRANE PROTEIN; PADGEM PROTEIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; HEMOPHILIA A; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCOAGULABILITY; LIGHT SCATTERING; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

ANIMALS; BLOOD PLATELETS; CELL ADHESION MOLECULES; E-SELECTIN; FACTOR VIII; FLOW CYTOMETRY; HUMANS; MICROBODIES; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SWINE; VON WILLEBRAND FACTOR;

EID: 0031887101     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199803)57:3<200::AID-AJH3>3.0.CO;2-Z     Document Type: Article

References (30)

1. Gringeri A, Santagostino E, Tradati F, Giangrande PLF, Mannucci PM: Adverse effects of treatment with porcine factor VIII. Thromb Haemost 65:245, 1991.
2. Lozier JN, Sanatagostino E, Kaspar CK, Teitel JM, Hay CR: Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors. Semin Hematol 30:10, 1993.
3. Altieri DC, Capitanio AM, Mannucci PM: Von Willebrand factor contaminating porcine factor VIII (Hyate: C) causes platelet aggregation. Br J Haematol 63:703, 1986.
4. Pareti FI, Mazzucato M, Bottini E, Mannucci PM: Interaction of porcine factor von Willebrand factor with the platelet glycoproteins Iband IIb/IIIa complex. Br J Haematol 82:81, 1992.
5. Mazzucato M, De Marco L, Pradella P, Masotti A, Pareti FI. Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx. Thromb Haemost 76:655, 1996.
6. Kernoff PBA, Thomas ND, Lilley PA, Matthews KB, Goldman E, Tuddenham EGD: Clinical experience with polyelectrolyte fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to Factor VIII. Blood 63:31, 1984.
7. Brettler DB, Forberg AD, Levine PH, Aledort LM, Hilgartner MW, Kasper CK, Lusher JM, McMillan C, Roberts H, The Cooperating Investigators: The use of porcine factore VIII concentrate (HYATE:C) in the treatment of patients with inhibitor antibodies to factor VIII. Arch Int Med 1249:1381, 1989.
8. Hay CRM, Lozier JN, Lee CA, Lafan M, Tradati H, Santagostino E, Ciavarella N, Schiavoni M, Fukui H, Yoshioka A, Teitel J, Mannucci PM, Kasper CK: Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects. Semin Hematol 31(Suppl 4):20, 1994.
9. Negrier C: The use of porcine factor VIII in France. Semin Hematol 31(Suppl 4):29, 1994.
10. Kühne T, Hornstein A, Semple J, Chang W, Blanchette V, Freedman J. Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole. Am J Hematol 50:40, 1995.
11. Gordon N, Thom J, Cole C, Baker R: Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry. Br J Haematol 89:117, 1995.
12. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ: Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 75:128, 1990.
13. Michelson AD, Barnard MR: Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood 70:1673, 1987.
14. Forbes CD, Prentice CRM: Aggregation of human platelets by purified porcine and bovine antihaemophilic factor. Nature: New Biology 241: 149, 1973.
15. Middleton S: Polyelectrolytes and preparation of Factor VIII:C. In Forbes CD, Lowe GD (eds): "Unresolved Problems in Hemophilia." Lancaster: MTP Press, 1982, pp 109-120.
16. George PN, Pickett EB, Heinz R: Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 68:307, 1986.
17. Michelson AD: Flow cytometry: A clinical test of platelet function. Blood 87:4925, 1996.
18. Janes SJ, Wilson DJ, Chronos N, Goodall AH: Evaluation of whole blood flow cytometric detection of platelet bound fibrinogen on normal subjects and patients with activated platelets. Thromb Haemost 70:659, 1993.
19. Sims PJ, Wiedmer T, Weiss HJ, Shattil SJ: Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J Biol Chem 264:17049, 1989.
20. Fox JB, Austin CD, Reynolds CC, Steffen PK: Evidence that agonist-induced activation of calpain causes the shedding of procoagulantcontaining microparticles from the membrane of aggregating platelets. J Biol Chem 266:13289, 1991.
21. Wiedmer T, Shattil SJ, Cunningham M, Sims PJ. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet Factor Va receptor. Biochemistry 29:623, 1988.
22. Gilbert JE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ: Platelet-derived microparticles express high affinity receptors for Factor VIII. J Biol Chem 266:17261, 1991.
23. Hoffman M, Munove DM, Roberts HR: Coagulation factor IXa binding to activated platelets and platelet derived microparticles: A flow cytometry study. Thomb Haemost 68:74, 1992.
24. Owens MR, Holme S, Cardinali S: Platelet microparticles adhere to subendothelium and promote adhesion of platelets. Thromb Res 66: 2475, 1992.
25. McGill M, Fugman DA, Vittorio N, Darrow C: Platelet membrane microparticles reduced microvascular bleeding times in thrombocytopenic rabbits. Lab Clin Med 109:127, 1987.
26. Howard MA, Coghlan M, David R, Pfueller SL: Coagulation activities of plasma microparticles. Thromb Res 50:145, 1988.
27. Warkentin TE, Hayward CPM, Boshkov L, Santos AV, Sheppard JA, Bode AP, Kelton JG: Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84:3691, 1994.
28. Galli M, Grassi A, Barbui T: Platelet-derived microparticles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Haemost 75:427, 1996.
29. Lee YJ, Jy W, Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS: Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementia. Thromb Res 72:295, 1993.
30. Jy W, Horstman LL, Arce M, Ahn YS: Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 119:334, 1992.